Scientific Programme
Preconference Course on Viral respiratory infections in infants
Chairs: L. Bont, P. Manzoni
11:30-12:00
Registrations
12:00-12:10
Opening
12:10-12:20
Opening lecture: the year in review
Louis Bont, The Netherlands
12:30-14:00
First session
What neonatologists need to know about COVID
12:30-13:00
Neonatal COVID disease: an overview after two years of pandemic
Pablo Sanchez, USA
13:00-13:30
Nutrition and specific Nutrients as a protective measure for Covid-19: are there any opportunities? Which is the role of breastfeeding?
Hans van Goudoever, The Netherlands
13:30-14:00
Interactions with other viruses, including altered seasonality
Dan Weinberger, USA
14:00-14:30
Coffee Break & sponsors’ exhibition
14:30-16:00
Second session
Passive RSV immunoprophylaxis
14:30-15:00
Next generation RSV mAbs
Octavio Ramilo, USA
15:00-15:30
Nirsevimab trial results
Paolo Manzoni, Italy
15:30-16:00
Long term consequences of RSV: the current state-of-the-art and the perspectives with the new mAbs
Eugenio Baraldi, Italy
16:00-17:00
Industry supported session
17:00-19:00
Third session
Maternal vaccination against respiratory pathogens
17:00-17:30
An overview and update about maternal vaccines and maternal vaccination strategies
Marta Nunes, South Africa
17:30-18:00
Maternal Pertussis vaccination during pregnancy
Scott Halperin, Canada
18:00-18:30
Maternal SARS-CoV-2 vaccination: what do we know after two years?
Paul Heath, UK
18:30-19:00
Closing remarks
09:00-09:15
Introduction and opening ceremony
Paolo Manzoni, Italy
09:15-09:40
Opening Lecture: Which are the game-changer RCTs in neonates in the last 5 years?
Neena Modi, UK
09:40-10:30
Respiratory session
09:40-10:05
Ventilatory strategies and late respiratory outcomes
Eduardo Bancalari, USA
10:05-10:30
Strategies of management for neonatal transition and acute RDS: which measurable health, long- term benefits?
Gianluca Lista, Italy
10:30-11:30
Coffee break - Exhibition
11:30-12:20
Nutrition session
11:30-11:55
Nutrition in the NICU and late outcomes
Hans Van Goudoever, The Netherlands
11:55-12:20
Milk-based bionutrient trials to improve outcomes in preterm infants: challenges and opportunities
Nick Embleton, UK
12:20-13:50
INDUSTRY SUPPORTED SESSION
13:50-15:05
Quality improvement to prevent infections and NEC – part 1
13:50-14:15
Quality improvements and their preventive effect on NEC
Neena Modi, UK
14:15-14:40
Maternal origins of neonatal infections: what do Ob-Gyns could/should do?
Bianca Masturzo, Italy
14:40-15:05
Bundles of quality improvement in neonatology: which measurable impact on infections
David Kaufman, USA
15:05-16:05
INDUSTRY SUPPORTED SESSION
16:05-17:30
Quality improvement to prevent infections and NEC – part 2
16:05-16:30
Quality improvements to contrast spreading out of MDR pathogens in neonatology
Pablo Sanchez, USA
16:30-16:55
Vertical transmission of Covid-19: does it happen? how to prevent?
Daniele De Luca, France
16:55-17:20
Neonatal and infant myocarditis by SARS-CoV-2 and Covid-19 vaccine: which is the truth?
Gerard Martin, USA
17:20-17:30
Closing
09:00-09:10
Opening
09:10-10:25
Innovation and prevention of late sensorial and neurodevelopmental negative outcomes
09:10-09:35
Can Innovation, Technology and Telemedicine in the NICU impact on late outcomes of prematurity in a measurable fashion?
Guilherme Sant’Anna, Canada
09:35-10:00
Metabolic and genetic investigations to prevent neonatal morbidity: which added value?
Alessandro Mussa, Torino
10:00-10:25
Prevention of negative late neurodevelopmental outcomes of prematurity: which evidence-based interventions
Luca A. Ramenghi, Italy
10:25-11:25
Industry supported session
11:25-12:15
Current and future options
11:25-11:50
Improving ROP outcomes: Ranibizumab vs laser
Andreas Stahl, Germany
11:50-12:15
Ten years of cord clamping in delivery room: which measurable benefits for the newborns?
Nestor Vain, Argentina
12:15-12:20
Closing ceremony
12:15-12:45
Industry supported session
May 21st, 2022
16:00-17:00
Industry supported session
The Real World Experience of Palivizumab against Respiratory Syncytial virus infection since 1998: A heritage of immunoprophylaxis
Chairs: Paolo Manzoni, Italy & Louis Bont, Netherlands
Speaker: Manuel Sanchez Luna, Spain
Speaker: Manuel Sanchez Luna, Spain
session supported by ASTRAZENECA
May 22nd, 2022
12:20-13:50
Respiratory infection in infants and the Covid-19 era
Paolo Manzoni, Italy
Speakers: Paolo Manzoni, Italy; Octavio Ramilo, USA; Louis Bont, The Netherlands
Speakers: Paolo Manzoni, Italy; Octavio Ramilo, USA; Louis Bont, The Netherlands
12:20-12:25
Welcome and Introduction
Few words on Rattle program and objective of symposium
Paolo Manzoni, Italy
12:25-12:45
Topic 1 – What is RSV real impact of disease and how has it been impacted during the COVID pandemic ERA? - Epidemiology in all infants
- Seasonality
- Perceptions
- Urgency more than ever to protect all infants
Paolo Manzoni, Italy
12:45-12:50
Discussion Panel
Chair and Panel
12:50-13:10
Topic 2 – What can we learn from recent trends? And what we expect in the near future? - The risk of having Non interventional preventive measures (masks and quarantine) and entire naïve cohorts
- Burden of RSV disease in the future
- Outpatient/inpatient perspectives
Octavio Ramilo, USA
13:10-13:15
Discussion Panel
Chair and Panel
13:15-13:35
Topic 3 – Can we talk about long post-RSV infection? - How viral respiratory disease originate later in life sequelae
- Comparison with post Covid
- Wheezing, Asthma, etc from RSV
Louis Bont, The Netherlands
13:35-13:40
Discussion Panel
Chair and Panel
13:40-13:50
Question & Answer. Closing remarks
Paolo Manzoni, Italy
session supported by SANOFI
15:05-16:05
Foetal Growth, Metabolism, and Angiogenesis: Exploring the Critical Impact on Pulmonary and Neurological Outcomes after Extremely Preterm Birth
Speakers: Steve Abman, USA; Boris Kramer, the Netherlands
session supported by OAK HILL BIO
May 23rd, 2022
10:25-11:45
The Role of Nutrition in Infant Intestinal Development, Health, and Long-term Implications
Eubiotic and Dysbiotic State
Fayez Ghishan, USA
Prebiotics, Oligosaccharides, & Lactose
Yvan Vandenplas, Belgium
Lactoferrin & MFGM
Paolo Manzoni, Italy
session supported by BYHEART
12:35-13:10
Current scientific evidence on the long-term impact of Palivizumab immunoprophylaxis in infants
Chair: Paolo Manzoni, Italy
Speaker: Eugenio Baraldi, Italy
Speaker: Eugenio Baraldi, Italy
session supported by ASTRAZENECA